Hemizygous Granzyme A Mice Expressing the hSOD1G93A Transgene Show Slightly Extended Lifespan
Open Access
- 4 November 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (21) , 13554
Abstract
Granzyme A (gzmA), a serine protease involved in the modulation of the inflammatory immune response, is found at an elevated level in the serum from ALS patients. However, the influence of gzmA on the progression of ALS remains unclear. The aim of our work was to assess whether the absence of gzmA in an ALS murine model could help slow down the progression of the disease. Homozygous and hemizygous gzmA-deficient mice expressing the hSOD1G93A transgene were generated, and survival of these mice was monitored. Subsequently, gene and protein expression of inflammatory and oxidative stress markers was measured in the spinal cord and quadriceps of these mice. We observed the longest lifespan in gzmA+/− mice. GzmA gene and protein expression was downregulated in the spinal cord and serum from gmzA+/− mice, confirming that the increased survival of hemizygous mice is correlated with lower levels of gzmA. In addition, mRNA and protein levels of glutathione reductase (GSR), involved in oxidative stress, were found downregulated in the spinal cord and quadriceps of gmzA+/− mice, together with lower IL-1β and IL-6 mRNA levels in hemyzigous mice. In summary, our findings indicate for the first time that reduced levels, but not the absence, of gzmA could slightly ameliorate the disease progression in this animal model.Keywords
Funding Information
- Instituto de Salud Carlos III (PI21/00372)
- Fondo Europeo de Desarrollo Regional (FEDER) “Una manera de hacer Europa” from the European Union, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CB18/05/0037)
- Consolidated Groups from Gobierno de Aragón
- Departamento de Industria e Innovación from Gobierno de Aragón and Fondo Social Europeo
- FEDER (Fondo Europeo de Desarrollo Regional)
- Gobierno de Aragon (Group B29_20R)
- Ministerio de Ciencia, Innovación y Universidades (MCNU)
- Agencia Estatal de Investigación (PID2020-113963RBI00)
- Postdoctoral Juan de la Cierva Contract
- CIBER -Consorcio Centro de Investigación Biomédica en Red (CB21/13/00087)
This publication has 63 references indexed in Scilit:
- The Role of the Innate Immune System in ALSFrontiers in Pharmacology, 2012
- A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosisDisease Models & Mechanisms, 2011
- Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesisProceedings of the National Academy of Sciences, 2010
- CD8 + T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitabilityThe FASEB Journal, 2009
- Human and Mouse Granzyme A Induce a Proinflammatory Cytokine ResponseImmunity, 2008
- Oxidative stress biomarkers in sporadic ALSAmyotrophic Lateral Sclerosis, 2008
- Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysisJournal of Cell Biology, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Presence of 4‐hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosisAnnals of Neurology, 1998
- In Vitro– and Ex Vivo–derived Cytolytic Leukocytes from Granzyme A × B Double Knockout Mice Are Defective in Granule-mediated Apoptosis but not Lysis of Target CellsJournal of Experimental Medicine, 1997